SMARCA4/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer
Bell, E. H., Chakraborty, A. R., Mo, X., Liu, Z., Shilo, K., Kirste, S., Stegmaier, P., McNulty, M., Karachaliou, N., Rosell, R., Bepler, G., Carbone, D. P., Chakravarti, A.Langue:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-1468
Date:
December, 2015
Fichier:
PDF, 10.87 MB
english, 2015
File converter
Plus de résultats de recherche
More benefits 
